U.S. PFAS Testing Market Size, Share, Trends and Forecast 2026-2035

U.S. PFAS Testing Market Size and Overview

The U.S. PFAS testing market reached US$ 199.16 million in 2025 and is expected to reach US$ 739.24 million by 2035, growing with a CAGR of 14.4% during the forecast period 2026-2035. The market is being driven by expanding regulatory monitoring, environmental remediation requirements, and growing demand for ultra-trace analytical testing across water, soil, wastewater, biosolids, food, consumer products, and industrial samples. PFAS contamination is now addressed across multiple regulatory frameworks, with the EPA's drinking-water regulation establishing enforceable limits for PFOA, PFOS, PFHxS, PFNA, HFPO-DA and certain PFAS mixtures. In May 2026, EPA proposed changes to implementation timelines while maintaining the federal PFOA and PFOS limits, keeping compliance testing relevant for public water systems.

Testing requirements are also becoming more technically standardized. EPA Methods 533 and 537.1 enable laboratories to measure 29 PFAS in drinking water, while Method 1633/1633A covers 40 PFAS across wastewater, surface water, groundwater, soil, biosolids, sediment, landfill leachate and fish tissue. This broader analytical scope is expanding demand for laboratories with LC-MS/MS capabilities, low detection limits, isotope-dilution expertise and validated PFAS workflows.

White-Space Opportunities for Decentralized PFAS Testing and Community-Level Monitoring

The expansion of PFAS monitoring beyond large municipal water systems is creating opportunities for localized and accessible testing services. In 2025, North Carolina DEQ directed Chemours to expand PFAS sampling eligibility to around 150,000 additional residences near the Fayetteville Works site, increasing the need for private-well sampling and laboratory analysis. In addition, EPA announced $30.7 million in 2026 technical-assistance funding for small and rural communities addressing drinking-water challenges, including PFAS. This creates white space for laboratories offering residential testing, sampling logistics, affordable testing packages and community-scale monitoring services.

The development of local laboratory infrastructure also presents an opportunity to reduce dependence on centralized testing providers. In 2025, WSSC Water opened an expanded water-quality laboratory in Maryland with a dedicated on-site PFAS laboratory, increasing its capacity to conduct PFAS analysis locally. This trend creates opportunities for testing companies to provide decentralized PFAS laboratories, laboratory outsourcing partnerships, mobile sampling support and rapid-turnaround analytical services for utilities and communities seeking faster access to PFAS testing capabilities.

PFAS Testing Key Takeaways

• In 2025, regulatory compliance testing applications and use cases led the market with a share of approximately 38.47%.
• Industrial process testing is the fastest-growing application and use case in 2025, with a CAGR 15.9%.
• PFAS regulations introduced by the U.S. Environmental Protection Agency (EPA) and global environmental agencies are major drivers accelerating demand for PFAS testing services due to increasing mandatory monitoring requirements across drinking water systems, industrial facilities, wastewater treatment plants, and environmental remediation projects.
• Eurofins Scientific, SGS SA, Intertek Group plc, and Agilent Technologies are strengthening market growth through expansion of advanced analytical laboratory networks, adoption of LC-MS/MS and high-resolution mass spectrometry technologies, and development of ultra-trace PFAS detection capabilities for environmental, industrial, and public health compliance applications.

U.S. PFAS Testing Industry Trends and Strategic Insight 

• The PFAS testing market is undergoing rapid transformation into ultra-trace analytical techniques like LC-MS/MS, HRMS, and non-target analysis due to growing regulatory pressures and demands for extensive PFAS analytes. Firms such as SGS SA, Eurofins Scientific, and Intertek Group Plc have been enhancing their analytical capacities and laboratories for various applications of drinking water, industry, and the environment.
• The PFAS testing industry is seeing an increasing shift towards extensive multi-matrix testing services such as testing in drinking water, waste water, biosolids, food packaging materials, healthcare products, and semiconductor manufacturing facilities. The firms that are making significant progress in terms of EPA 1633 compliant testing, contamination risk assessment, and automation of analysis include SGS and Eurofins.
• Growing environmental remediation projects, stringent contaminant concentration limits, and higher compliance in industries are driving the demand for scalable PFAS testing solutions from leading firms such as ALS Limited, Montrose Environmental Group.

Market Scope

U.S. PFAS Testing Disruption Analysis

Rapid regulatory changes continuously reshaping U.S. laboratory testing requirements

The disruptive nature of the U.S. PFAS testing market is primarily driven by the rapid evolution of federal and state-level regulatory requirements. The U.S. EPA continues to develop and revise PFAS standards, analytical methods, monitoring requirements, and reporting obligations across drinking water, wastewater, biosolids, contaminated sites, and industrial applications. These changes are forcing laboratories to continuously validate new methods, expand analyte coverage, maintain accreditation, and upgrade compliance capabilities, disrupting traditional testing workflows and increasing the need for specialized PFAS laboratories.

Technological disruption is accelerating as U.S. laboratories move beyond conventional targeted analysis toward high-resolution mass spectrometry (HRMS), non-targeted analysis (NTA), ultra-trace detection, and broader PFAS screening. The growing need to identify emerging and previously uncharacterized PFAS is challenging laboratories that rely primarily on established targeted methods. Testing providers are therefore investing in advanced instrumentation, automated sample preparation, data-processing platforms, and AI-enabled analytical workflows to improve analyte identification, detection sensitivity, throughput, and turnaround times.

U.S. PFAS Testing BCG Matrix: Company Evaluation 

Star companies are Eurofins Scientific, SGS SA, and Intertek Group plc due to their broad U.S. laboratory networks, established PFAS testing capabilities, extensive environmental testing portfolios, and strong regulatory expertise. Their ability to serve industrial, municipal, government, and remediation requirements supports their leading positions in the U.S. PFAS testing market.

Question mark companies are ALS Limited and Bureau Veritas due to their established environmental testing platforms and expanding PFAS capabilities, providing scope to strengthen their U.S. market positions. Potential companies are Montrose Environmental Group, Waters Corporation, and Agilent Technologies, supported by specialized environmental, analytical, and instrumentation capabilities, while Element Materials Technology is positioned as a Tailender due to its comparatively narrower PFAS market positioning.

U.S. PFAS Testing Market Dynamics          

Driver Impact Analysis

Stringent PFAS regulations by the United States Environmental Protection Agency and global regulatory agencies are increasing mandatory testing requirements

Stringent PFAS regulations imposed by the US EPA and other international agencies are rapidly leading to mandatory testing requirements in drinking water systems, industry, and environmental monitoring programs. As per EPA in May 2025, the EPA is ensuring the continued existence of National Primary Drinking Water Regulations (NPDWRs) for PFOA and PFOS while allowing additional time for compliance, emphasizing the long-term requirement for public water systems and laboratories to conduct ongoing monitoring. The EPA has further provided guidelines on implementation, laboratory testing requirements, and analytical methods, which include EPA Method 537.1, as part of PFAS monitoring programs. Additionally, the EPA requires public water systems to implement initial PFAS monitoring before 2027 and subsequent compliance monitoring programs thereafter.

With the emergence of increasingly strict regulations, there is a substantial push towards investments in laboratory facilities, technology, and environmental compliance programs. For instance, as per the report by the EPA, the final rule on the PFAS drinking water regulation will be able to protect more than 100 million individuals from exposure to PFAS chemicals, and prevent several deaths and severe illnesses as well. Additionally, it was reported that the EPA will fund USD 1 billion under the Infrastructure Investment and Jobs Act to help out with the implementation of PFAS testing and treatments in public water systems. With increasing regulations, there will be growing adoption of cutting-edge technology, including LC-MS/MS and high resolution mass spectrometry, which will help in attaining ultra-trace detection limits for regulated PFAS. As regulations keep evolving and contamination limits are lowered further, lab reports become more stringent, and there are stricter restrictions on the industry’s discharges; PFAS testing has become a crucial obligation in the long run.

Restraint Impact Analysis

Extremely low detection limit requirements increase quality control complexity

Ultra-low detection limits present significant operational and quality control challenges for laboratories analyzing PFAS worldwide. Modern PFAS regulation often calls for ultra-low detection limits, which necessitate the use of ultra-clean analytical spaces and sensitive testing. Laboratory contamination, whether through tubing, solvents, gloves, protective clothing, or sample containers, may lead to inaccurate results and false positives. This leads to an increase in re-tests, quality control difficulties, and operational costs for testing laboratories.

Furthermore, laboratories are forced to ensure calibration verifications, duplication tests, blank analyses, and intricate sample preparations to stay up to date with regulatory standards. The growing trend in terms of expanding analyte lists from traditional PFAS substances to short-chain and novel fluorine-containing substances has been leading to a growing need for advanced testing. Testing laboratories are therefore under pressure to acquire liquid chromatography mass spectrometry systems, cleanrooms, automation, and train their staff. This operational and capital cost burden poses a challenge when scaling up operations, especially for small and medium-sized laboratories that wish to expand PFAS testing facilities.

U.S. PFAS Testing Segment Analysis    

The U.S. PFAS testing market is segmented based on offering, testing method, technology, PFAS type, sample type, application, and region.

Increasing Regulatory Monitoring Requirements for Drinking Water Safety are Driving Demand for PFAS Drinking Water Testing

The drinking water testing segment is a leading application area in the U.S. PFAS testing market, driven by EPA monitoring requirements, increasing PFAS occurrence concerns, and stricter drinking water safety requirements. Under the EPA’s Fifth Unregulated Contaminant Monitoring Rule (UCMR 5), public water systems monitored for 29 PFAS between 2023 and 2025, generating nationwide data on PFAS occurrence in drinking water. The EPA’s approved drinking water methods, including Methods 533 and 537.1 using LC-MS/MS, enable laboratories to detect PFAS at very low concentrations required for regulatory monitoring and compliance.

U.S. laboratories are expanding PFAS testing capabilities to support regulatory monitoring and drinking water compliance. For instance, in 2026, the EPA published its updated list of laboratories approved for UCMR 5, confirming laboratories that met EPA method and proficiency-testing requirements for PFAS analysis. The EPA also continues to update UCMR 5 analytical results, with data available for approximately 95% of the expected results as of 2026, increasing the need for laboratory capacity to analyze and monitor PFAS in public water systems. This continued expansion of approved laboratory capabilities demonstrates the growing role of specialized PFAS testing services in supporting drinking water monitoring across the U.S.

U.S. PFAS Testing Regulatory Analysis

Increasing EPA Drinking Water Requirements are Driving PFAS Testing Demand: The U.S. EPA established enforceable drinking water limits of 4.0 ppt for PFOA and PFOS under its 2024 PFAS National Primary Drinking Water Regulation. In 2026, EPA proposed retaining the PFOA and PFOS requirements while reconsidering limits for several other PFAS. Continued federal focus on PFOA and PFOS is supporting demand for low-level PFAS testing among public water systems and laboratories.

UCMR 5 and EPA-Approved Testing Methods are Expanding Laboratory Requirements: UCMR 5 required monitoring of 29 PFAS in public water systems during 2023 to 2025, generating extensive PFAS occurrence data across the U.S. EPA-approved Methods 533 and 537.1 require specialized LC-MS/MS capabilities for low-level detection, while laboratory qualification requirements create technical barriers for smaller providers. These requirements are increasing demand for specialized, regulatory-compliant PFAS testing laboratories.

Competitive Landscape

• Key players include Eurofins Scientific, SGS SA, ALS Limited, Intertek Group plc, Waters Corporation, Bureau Veritas, Agilent Technologies, Element Materials Technology, Montrose Environmental Group

Key Developments

• May 2025: The U.S. Environmental Protection Agency confirmed continued implementation of national drinking water standards for PFOA and PFOS, accelerating long-term demand for advanced PFAS laboratory testing and compliance monitoring services.
• March 2026: Waters corporation introduced a non-targeted PFAS screening workflow for biosolids using the Xevo MRT Mass Spectrometer, enabling the identification of previously uncharacterized PFAS isoforms beyond conventional targeted analysis.
• March 2026: Waters developed a direct-injection UPLC-MS/MS method for the combined analysis of anionic, cationic, and zwitterionic PFAS in environmental water samples, expanding analytical coverage across multiple PFAS classes.
• May 2026: Agilent launched its PFAS Analysis UHPLC system, designed to support reliable, high-throughput PFAS analysis with low detection limits. The platform incorporates PFAS-focused system configuration and demonstrates consistent performance across extended analytical runs. 

Key Procurement Priorities and Buyer Evaluation Criteria

• Firms that are making investments within the market for PFAS testing services are opting for vendors that can offer ultra-trace contamination testing, compliance-based analytical services, and scalable environmental testing infrastructure for water, soil, food, and industrial uses.
• Some aspects related to the procurement process of PFAS test service providers are being influenced by PFAS regulation changes, increased use of EPA 1633 and EPA 537.1 testing techniques, expansion of drinking water monitoring initiatives, and increased demand for advanced analytical instruments in the industrial sector (LC-MS/MS and High-resolution Mass Spectrometry).
• Among several aspects of consideration in the procurement process are the level of analytical sensitivity, the status of laboratory accreditation, turnaround time, contamination controls, multi-matrix testing capabilities, and compliance with environmental and public health regulations.
• Other important factors considered include laboratory network size, non-targeted analysis services, automated sample preparation technology, analytical data quality, and the capability of working with complex applications like wastewater monitoring, remediation programs, industrial process verification, healthcare testing, and consumer product contamination studies.

Why Choose DataM?

• Technological Innovations: Explores advancements in PFAS analytical technologies including LC-MS/MS, high-resolution mass spectrometry (HRMS), combustion ion chromatography (CIC), and non-targeted analysis (NTA), enabling ultra-trace contamination detection, broader analyte coverage, and improved regulatory compliance across drinking water, environmental, industrial, and healthcare applications.
• Product Performance & Market Positioning: Evaluates how different market participants deliver PFAS testing solutions based on analytical sensitivity, turnaround time, contamination-control capability, multi-matrix testing expertise, and regulatory accreditation, highlighting how leading companies differentiate through advanced laboratory infrastructure and scalable analytical services.
• Real-World Evidence: Highlights increasing adoption of PFAS testing across drinking water systems, wastewater treatment plants, semiconductor manufacturing facilities, food packaging, healthcare products, and environmental remediation projects, demonstrating benefits such as improved contamination monitoring, regulatory compliance, public health protection, and industrial risk management.
• Market Updates & Industry Changes: Tracks key developments including laboratory expansions, EPA Method 1633 adoption, non-targeted PFAS screening advancements, accreditation upgrades, and increasing investments in environmental testing infrastructure across North America, Europe, and Asia-Pacific markets.
• Competitive Strategies: Analyzes how leading companies expand through laboratory acquisitions, advanced analytical technology adoption, regulatory-compliance partnerships, automation integration, and expansion of PFAS analyte coverage to address rising testing demand from environmental and industrial sectors.
• Pricing & Market Access: Explains pricing variations based on detection limits, sample complexity, testing methodology, accreditation requirements, and turnaround time, along with market access through environmental laboratories, industrial testing providers, regulatory agencies, and specialized analytical service companies.
• Market Entry & Expansion: Identifies growth opportunities driven by tightening PFAS regulations, expanding drinking water monitoring programs, rising remediation projects, and increasing industrial compliance requirements, while outlining strategies such as laboratory network expansion, technology differentiation, and advanced analytical capability development to strengthen market presence.

Target Audience

• Environmental Testing Laboratories: Commercial, government, and independent laboratories providing PFAS analytical, contamination monitoring, and regulatory compliance testing services.
• Water Utilities & Municipal Authorities: Public water systems, wastewater treatment operators, and municipal agencies implementing PFAS monitoring and drinking water compliance programs.
• Industrial Manufacturers: Chemical, semiconductor, electronics, aerospace, food processing, textile, and industrial manufacturing companies conducting PFAS contamination assessment and process monitoring activities.
• Healthcare & Pharmaceutical Companies: Medical device manufacturers, pharmaceutical companies, and healthcare organizations performing PFAS screening, extractables and leachables testing, and contamination-risk assessments.
• Government & Regulatory Bodies: Environmental protection agencies, public health authorities, defense organizations, and policymakers strengthening PFAS regulations, remediation programs, and environmental monitoring frameworks.
• Investors & Private Equity Firms: Stakeholders monitoring growth opportunities in environmental testing, laboratory infrastructure, analytical instrumentation, water treatment, and contamination remediation markets.
• Analytical Instrumentation & Supply Chain Providers: Companies supplying LC-MS/MS systems, HRMS platforms, laboratory consumables, reference materials, sample preparation products, and environmental analytical software solutions.